Finanzwire Finanzwire
Basculer en Français
11167 Companies
246614 Keywords
174566 Articles
133203 Press releases
Headlines Articles Press releases Fresenius SE & Co. KGaA Remove
  1. Home
  2. Companies
  3. Fresenius SE & Co. KGaA
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/07/2024 at 21:24, 2 years 5 months ago

    Fresenius SE & Co. KGaA Increases 2024 Financial Outlook

    Revenue Growth 2024 Outlook EBIT Margin Fresenius Kabi Fresenius SE & Co. KGaA
  • PRESS RELEASE

    published on 05/07/2024 at 21:19, 2 years 5 months ago

    EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024

    Fresenius SE & Co. KGaA raises outlook for fiscal year 2024 based on strong first quarter performance and improved business prospects for Fresenius Kabi
    Revenue Growth Fiscal Year 2024 EBIT Margin Outlook Fresenius SE & Co. KGaA
    Logo of Fresenius SE & Co. KGaA
  • PRESS RELEASE

    published on 02/21/2023 at 19:02, 3 years 7 months ago

    EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)

    Logo of Fresenius SE & Co. KGaA
  • PRESS RELEASE

    published on 02/09/2023 at 16:24, 3 years 8 months ago

    EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation

    Logo of Fresenius SE & Co. KGaA
Previous page
1 ... 3 4
Accesswire
  • Published on 10/13/2026 at 17:15, 40 minutes ago

    Caldwell Names John Staines as Partner and Leader of Global HR Practice

  • Published on 10/13/2026 at 15:00, 2 hours 55 minutes ago

    Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend

  • Published on 10/13/2026 at 14:45, 3 hours 10 minutes ago

    Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

  • Published on 10/13/2026 at 14:31, 3 hours 24 minutes ago

    First Breach Completes First Autonomous Flight of Proprietary Drone Prototype

  • Published on 10/13/2026 at 14:10, 3 hours 45 minutes ago

    NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements

View all ACCESSWIRE
EQS Group
  • Published on 10/13/2026 at 16:15, 1 hour 39 minutes ago

    CGTN: A Mountain Road That Transformed a Village

  • Published on 10/13/2026 at 15:10, 2 hours 44 minutes ago

    CurTec expands US manufacturing and warehouse capacity in Westminster, S.C.

  • Published on 10/13/2026 at 15:06, 2 hours 48 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 10/13/2026 at 15:05, 2 hours 49 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

  • Published on 10/13/2026 at 15:05, 2 hours 49 minutes ago

    Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats

View all EQS
Les Echos
  • Published on 10/13/2026 at 17:45, 9 minutes ago

    ENGIE and CMA CGM join forces to invest in biomethane production in Le Havre

  • Published on 10/13/2026 at 09:04, 8 hours 50 minutes ago

    Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards

  • Published on 10/12/2026 at 17:59, 23 hours 55 minutes ago

    Reporting on share buyback transactions carried out between October 7 and October 9, 2026

  • Published on 10/12/2026 at 17:45, 1 day ago

    Weekly share buyback

  • Published on 10/12/2026 at 17:45, 1 day ago

    Declaration of transactions on own shares from October 5, 2026 to October 11, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy